Key appointment to support company in scaling biorepository and stability storage operationsRochdale, UK, 28 April 2025: ...

Robust project management is essential in any manufacturing business, particularly where strict regulations and complex ...

Aviva’s in-house capital unit that invests in a range of infrastructure and real estate projects, and mixed-use developer ...

Late-breaking oral presentation to highlight further evidence supporting potential for deupirfenidone to serve as a new standard of care for the treatment of idiopathic pulmonary fibrosis (IPF) ...

SIOUX FALLS, SD / ACCESS Newswire / May 1, 2025 / Teen mental health has reached a crisis point in the United States. According to the CDC, nearly 1 in 3 high school girls reported seriously ...

Cash Burn of $4.0 million in Q1 remains in line with projected quarterly rangeCash and investments on hand are sufficient to fund operations beyond the anticipated FDA decision of VenoValve and the ...

BRIDGEWATER, NJ / ACCESS Newswire / May 1, 2025 / Tharimmune, Inc., (Nasdaq:THAR) ("Tharimmune" or the "Company") a clinical-stage biopharmaceutical company focused on developing innovative ...

Clinigen, the global specialist pharmaceutical services group, today announced the appointment of Nihad Hasagic as Senior Vice President for Clinigen Lifecycle Services (SVP CLS). Reporting to the ...

Cambridge Cognition Holdings plc (AIM: COG), the brain health software group specialising in digital products to advance clinical research and patient treatment, announces its preliminary unaudited ...

Aspira Women's Health Submits the Third Milestone of ARPA-H $10 Million Award  AUSTIN, TX / ACCESS Newswire / May 1, 2025 / Aspira Women's Health Inc. ("Aspira") (OTC PINK:AWHL), a bio-analytical ...

Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces the appointment of Shinya Tsuzuki, as Head of Investor Relations. Mr. Tsuzuki will lead Nxera’s Investor Relations (IR) team ...

VYVGART® is first-and-only targeted IgG Fc-antibody fragment for CIDPFirst novel mechanism of action for CIDP treatment in more than 30 yearsCHMP positive opinion based on ADHERE data, the largest ...